Influenza vaccine adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Influenza vaccine}} {{CMG}}; {{AE}} {{MM}} ==Adverse Reactions== The most common (≥10%) injection-site reaction was pain (>37%); the most common (≥10%) solicit..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{MM}} | {{CMG}}; {{AE}} {{MM}} | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
The most common (≥10%) injection-site reaction was pain (>37%); the most common (≥10%) solicited systemic adverse reactions were headache (>15%), fatigue (>15%) and myalgia (>11%).ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FLUBLOK (INFLUENZA VACCINE) INJECTION, SOLUTION [PROTEIN SCIENCES CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529 | publisher = | date = | accessdate}}</ref> | The most common (≥10%) injection-site reaction was pain (>37%); the most common (≥10%) solicited systemic adverse reactions were headache (>15%), fatigue (>15%) and myalgia (>11%).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FLUBLOK (INFLUENZA VACCINE) INJECTION, SOLUTION [PROTEIN SCIENCES CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529 | publisher = | date = | accessdate}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 14:18, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Adverse Reactions
The most common (≥10%) injection-site reaction was pain (>37%); the most common (≥10%) solicited systemic adverse reactions were headache (>15%), fatigue (>15%) and myalgia (>11%).[1]
References
- ↑ "FLUBLOK (INFLUENZA VACCINE) INJECTION, SOLUTION [PROTEIN SCIENCES CORPORATION]". Text " accessdate" ignored (help)
Adapted from the FDA Package Insert.